DarioHealth
The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
The expansion includes prescribing capabilities and entry into the direct-to-consumer market.
The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.
Twill by Dario will mark the company's entry into the Medicare Advantage market.
DarioHealth also relayed that its revenue increased by 1.7% in the second quarter of the year, compared to the same period last year.
The chronic care management company reported a 47% decrease in revenue in Q4 2023 compared to 2022 and a $7.3 million loss in year-over-year revenue.
Women's health company Tia adds two women to its all-female leadership team, Ophelia appoints a chief commercial officer and chief operations officer, and Noom adds new leadership.